Strategic Growth Zavation has recently expanded through the acquisition of Choice Spine and strategic leadership changes, signaling an active growth and integration phase. This presents opportunities to align product offerings with the combined entity’s portfolio and address expanded customer bases in orthopedic and spinal markets.

Leadership Transition With Lane Major stepping down as CEO and Derek Kuyper appointed for the combined organization, there is potential for renewed strategic initiatives and cross-sell of Zavation’s next‑gen cervical interbody solutions and Labyrinth porous PEEK technologies to new leadership’s priorities.

Next‑Gen Tech Zavation’s launch of next‑generation cervical interbody devices featuring NanoPrime and Labyrinth porous PEEK indicates a focus on advanced material science and innovative implants, offering upsell opportunities to surgeons seeking performance improvements and to distributors seeking differentiated products.

Org & Ops Fit The company’s scale and backend tech stack (SOLIDWORKS, Google Cloud, Smartsheet, WordPress/WooCommerce) support a nimble product development and customer delivery cycle, enabling SDRs to position Zavation as a modern, reliable supplier with streamlined ordering and strong distributor partnerships.

Market Positioning Zavation operates in the mid‑sized medical device segment with a revenue profile in the tens of millions, making it a compelling target for regional distributors and mid‑market hospitals seeking innovative spinal options to compete with larger players like Orthofix or SeaSpine.